SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-002547
Filing Date
2020-03-12
Accepted
2020-03-12 16:32:34
Documents
99
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nbrv-20191231x10k.htm 10-K 4555521
2 EX-4.1 nbrv-20191231ex41754b094.htm EX-4.1 107218
3 EX-10.10 nbrv-20191231ex1010572b8.htm EX-10.10 62461
4 EX-10.40 nbrv-20191231ex1040eec2b.htm EX-10.40 201304
5 EX-10.41 nbrv-20191231ex10413d837.htm EX-10.41 142007
6 EX-10.42 nbrv-20191231ex10422023b.htm EX-10.42 135438
7 EX-10.43 nbrv-20191231ex1043e47e7.htm EX-10.43 84090
8 EX-21.1 nbrv-20191231ex211f1dedf.htm EX-21.1 8521
9 EX-23.1 nbrv-20191231ex231e57868.htm EX-23.1 4808
10 EX-31.1 nbrv-20191231ex31146f075.htm EX-31.1 13464
11 EX-31.2 nbrv-20191231ex312f8ca0c.htm EX-31.2 12564
12 EX-32.1 nbrv-20191231ex321ee4ac4.htm EX-32.1 7296
13 EX-32.2 nbrv-20191231ex322b6271b.htm EX-32.2 7858
14 GRAPHIC nbrv20191231x10k001.jpg GRAPHIC 18255
  Complete submission text file 0001558370-20-002547.txt   14286732

Data Files

Seq Description Document Type Size
15 EX-101.INS nbrv-20191231.xml EX-101.INS 2701158
16 EX-101.SCH nbrv-20191231.xsd EX-101.SCH 77972
17 EX-101.CAL nbrv-20191231_cal.xml EX-101.CAL 83026
18 EX-101.DEF nbrv-20191231_def.xml EX-101.DEF 360957
19 EX-101.LAB nbrv-20191231_lab.xml EX-101.LAB 736597
20 EX-101.PRE nbrv-20191231_pre.xml EX-101.PRE 605935
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37558 | Film No.: 20709238
SIC: 2834 Pharmaceutical Preparations